Shares of Aehr Test Systems, Inc. (NASDAQ:AEHR) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results.
Aehr Test Systems reported quarterly earnings of 7 cents per share, which beat the analyst consensus estimate of 2 cents. Quarterly revenue of $13.12 million also beat the consensus estimate of $12.17 million, according to data from Benzinga Pro.
Aehr Test Systems shares jumped 13.9% to $15.17 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- NewGenIvf Group Limited (NASDAQ:NIVF) rose 68.4% to $1.0100 in pre-market trading. NIVF TW Opportunities Master Fund II, L.P. disclosed a 9.9% passive stake in NewgenIVF Group Ltd as of Oct. 4.
- ZenaTech Inc (NASDAQ:ZENA) gained 40.1% to $2.48 in pre-market trading after declining around 5% on Thursday.
- Cemtrex, Inc. (NASDAQ:CETX) shares rose 26.4% to $0.5930 in pre-market trading after declining 34% on Thursday.
- LuxUrban Hotels Inc. (NASDAQ:LUXH) shares gained 26.1% to $0.0637 in pre-market trading after dipping 17% on Thursday. LuxUrban Hotels recently filed a prospectus to sell up to 23.63 million shares of common stock.
- Jet.AI Inc. (NASDAQ:JTAI) shares surged 24.1% to $0.1014 in pre-market trading. Jet.AI shares fell around 12% on Thursday after the company announced it entered into an agreement with certain institutional investors to purchase approximately 26.6 million shares of common stock in a registered direct offering.
- American Lithium Corp. (NASDAQ:AMLI) gained 15% to $0.9086 in pre-market trading after jumping around 18% on Thursday.
- Kindly MD, Inc. (NASDAQ:KDLY) shares jumped 13.2% to $1.4500 in pre-market trading after declining around 7% on Thursday.
- Burning Rock Biotech Limited (NASDAQ:BNR) rose 12.3% to $3.67 in pre-market trading. Burning Rock and Dizal secured NMPA approval for NGS-based companion diagnostic for lung cancer in China.
- Akanda Corp. (NASDAQ:AKAN) gained 12% to $1.21 in pre-market trading.
Losers
Now Read This:
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
